Abstract
We evaluated effectiveness of exenatide in 81 unselected patients and compared the results with clinical trials. Patients achieved a similar reduction in A1C and lost more weight than patients in the clinical trials. Thirty-seven (46%) were treated off-label. Exenatide was effective on and off-label in this unselected patient group.
Original language | English (US) |
---|---|
Pages (from-to) | e4-e6 |
Journal | Diabetes Research and Clinical Practice |
Volume | 80 |
Issue number | 2 |
DOIs | |
State | Published - May 1 2008 |
Keywords
- Clinical trials
- Diabetes
- Exenatide
- Obesity
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology